Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

PURPOSE: The Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial established perioperative epirubicin, cisplatin, and fluorouracil chemotherapy as a standard of care for patients with resectable esophagogastric cancer. However, identification of patients at risk for relap...

Descripción completa

Detalles Bibliográficos
Autores principales: Smyth, Elizabeth C., Fassan, Matteo, Cunningham, David, Allum, William H., Okines, Alicia F.C., Lampis, Andrea, Hahne, Jens C., Rugge, Massimo, Peckitt, Clare, Nankivell, Matthew, Langley, Ruth, Ghidini, Michele, Braconi, Chiara, Wotherspoon, Andrew, Grabsch, Heike I., Valeri, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2016
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019747/
https://www.ncbi.nlm.nih.gov/pubmed/27298411
http://dx.doi.org/10.1200/JCO.2015.65.7692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019747/
https://www.ncbi.nlm.nih.gov/pubmed/27298411
http://dx.doi.org/10.1200/JCO.2015.65.7692

Ejemplares similares